Turkish registry for diagnosis and treatment of acute heart failure: TAKTIK study
| Autor: | Satiroglu, Omer, Yilmaz, Mehmet Birhan, DURSUNOĞLU, DURSUN, Erkoc, Sultanbaliz, Mutlu, Hasim, ONRAT, ERSEL, Temizhan, Ahmet, Gemici, Gokmen, Guvenc, Tolga Sinan, Helvaci, Aysen, Iltumur, Kenan, Bakirci, Murat, Iyigun, Ufuk, Kalay, Nihat, Acarturk, Esmeray, Eren, Mehmet, ZOGHİ, MEHDİ, Erer, Betul, Kirilmaz, Bahadir, Tuncer, Mustafa, Korkmaz, Hasan, Ekmekci, Cenk, Ekmekci, Ahmet, Duygu, Hamza, Deveci, Onur Sinan, Deveci, Bulent, Dede, Ozkan, Serdar, Osman Akin, Celebi, Savas, Oto, Ali, Ozcan, Turkay, ÇAVUŞOĞLU, YÜKSEL, Ciftci, Sema, Yilmaz, Yucel, DEMİRBAĞ, RECEP, Basarici, Ibrahim, Bulur, Serkan, Ozdemir, Kurtulus, Yilmaz, Remzi, Ozhan, Hakan, Yazici, Mehmet, Ulgen, Siddik, Teyyareci, Yelda, Ozturk, Sercan, ŞAHİN, MAHMUT, Sahin, Yildiray, Erol, Mustafa Kemal |
|---|---|
| Přispěvatelé: | OMÜ |
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Male
systolic blood pressure lcsh:Diseases of the circulatory (Cardiovascular) system Databases Factual Turkey peripheral edema lcsh:Medicine mortality rate registry physical examination Turkey (republic) 0302 clinical medicine cardiovascular mortality data base Surveys and Questionnaires dipeptidyl carboxypeptidase inhibitor heart rate Registries Myocardial infarction heart ejection fraction register Ejection fraction crackle adult valvular heart disease beta adrenergic receptor blocking agent digoxin Middle Aged cohort analysis inotropic agent health survey Hospitalization factual database Acute Disease Cardiology disease registry Female cerebrovascular accident Cardiology and Cardiovascular Medicine Cohort study heart failure with preserved ejection fraction lcsh:Internal medicine medicine.medical_specialty hypertension acute heart failure electrocardiography heart infarction Article 03 medical and health sciences Age Distribution turkey treatment refusal Internal medicine Heart rate medicine Humans human lcsh:RC31-1245 drug use Aged hospital mortality Heart Failure Internet business.industry questionnaire disease association lcsh:R Acute heart failure 030208 emergency & critical care medicine medicine.disease cold limb major clinical study Survival Analysis angiotensin receptor antagonist hospital admission Blood pressure age lcsh:RC666-701 Heart failure Heart failure with preserved ejection fraction business aldosterone antagonist |
| Zdroj: | Türk Kardiyoloji Derneği Arşivi, Vol 44, Iss 8, Pp 637-646 (2016) |
| Popis: | YILMAZ, MEHMET BIRHAN/0000-0002-8169-8628; YILMAZ, MEHMET BIRHAN B/0000-0002-8169-8628; Demirbag, Recep/0000-0001-7831-2715; Guvenc, Tolga Sinan/0000-0002-6738-266X; YILMAZ, Mehmet Birhan/0000-0002-8169-8628; Basarici, Ibrahim/0000-0003-4435-337X; Celebi, Aksuyek savas/0000-0002-3637-0711 WOS: 000392634300003 PubMed: 28045409 Objective: The goal of this study was to develop a national database of patients hospitalized in Turkey with acute heart failure (AHF) using evaluations of diagnostic and therapeutic approaches. Methods: Patient data were collected using an Internet-based survey. A total of 588 patients were enrolled from 36 participating medical centers across the country. Results: Mean age was 62 +/- 13 years and 38% of the patients were female. Ratio of de novo AHF to study cohort was 24%. Coronary heart disease and hypertension were found in 61% and 53% of the patients, respectively. Valvular heart disease was the underlying cause in 46% of heart failure patients. The most frequent factor associated with decompensation was noncompliance with treatment, observed in 34% of patients. Systolic blood pressure was 125 +/- 28 mmHg and heart rate was 93 +/- 22 beats/minute in the cohort. The most common findings on physical examination were inspiratory fine crackles (84%), peripheral edema (64%), and cold extremities in 34%. Mean ejection fraction (EF) measured at admission was 33 +/- 13%. Preserved EF (>=%40) was present in 20% of patients. On admission, 60%, 46%, and 40% of patients were using angiotens-in-converting enzyme inhibitor/angiotensin receptor blocker, beta-blocker, or aldosterone antagonist, respectively. In-hospital events were reported as 3.4% death, 1.6% stroke and 2% myocardial infarction. Conclusion: Compared to previous data collected around the world, AHF patients in Turkey were younger, had more frequently valvular heart disease as the underlying cause, and were more noncompliant with medical treatment, but overall mortality was lower. Drugs shown to reduce mortality, and which also form the basis of guideline-directed medical therapy, are still used inadequately. Turkish Society of Cardiology Turkish Society of Cardiology |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|